CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-22 | Zuga Matt CFO & Chief Business Officer | Sale | −1,687 | $1.86 | $3K | 304,924 |
| 2026-01-22 | OConnell Daniel Joseph Chief Executive Officer | Sale | −2,689 | $1.88 | $5K | 881,275 |
| 2026-01-22 | Barton Russell Chief Operating Officer | Sale | −462 | $1.84 | $850 | 205,092 |
| 2026-01-21 | Meisner Derek M Chief Legal Officer & Corp Sec | Sale | −2,247 | $1.81 | $4K | 180,686 |
| 2026-01-21 | Siemers Eric Chief Medical Officer | Sale | −2,331 | $1.80 | $4K | 256,266 |
| 2026-01-21 | Zuga Matt CFO & Chief Business Officer | Sale | −2,473 | $1.81 | $4K | 306,611 |
| 2026-01-21 | OConnell Daniel Joseph Chief Executive Officer | Sale | −9,346 | $1.81 | $17K | 883,964 |
| 2026-01-21 | Barton Russell Chief Operating Officer | Sale | −2,315 | $1.81 | $4K | 205,554 |
| 2026-01-20 | OConnell Daniel Joseph Chief Executive Officer | Grant or award | +299,800 | 893,310 | ||
| 2026-01-20 | OConnell Daniel Joseph Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +450,000 | 450,000 | ||
| 2026-01-16 | Zuga Matt CFO & Chief Business Officer | Grant or award | +99,133 | 309,084 | ||
| 2026-01-16 | Zuga Matt CFO & Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +148,700 | 148,700 | ||
| 2026-01-16 | Meisner Derek M Chief Legal Officer & Corp Sec | Grant or award | +99,133 | 182,933 | ||
| 2026-01-16 | Meisner Derek M Chief Legal Officer & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +148,700 | 148,700 | ||
| 2026-01-16 | Siemers Eric Chief Medical Officer | Grant or award | +99,133 | 258,597 | ||
| 2026-01-16 | Siemers Eric Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +148,700 | 148,700 | ||
| 2026-01-16 | Barton Russell Chief Operating Officer | Grant or award | +84,600 | 207,869 | ||
| 2026-01-16 | Barton Russell Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +126,900 | 126,900 | ||
| 2026-01-16 | Schacterle Amy Chief Regulatory Officer | Grant or award | +84,600 | 92,303 | ||
| 2026-01-16 | Schacterle Amy Chief Regulatory Officer | Grant or award · Employee Stock Option (right to buy) | +126,900 | 126,900 |
Page 3 of 13 · 246 trades